Bladder cancer screening: An update on urine-based tumor markers

Robert S. Svatek, Yair Lotan

Research output: Contribution to journalArticle

Abstract

Bladder cancer screening has the potential to improve survival in high-risk patients by detecting tumors early, resulting in better outcomes. While some urine-based bladder tumor markers have demonstrated an improvement in bladder cancer detection over cytology or hematuria testing, they need to be evaluated in the setting of screening. More research is required to assess the feasibility and cost-effectiveness of screening prior to widespread use.

Original languageEnglish (US)
Pages (from-to)12-19
Number of pages8
JournalContemporary Urology
Volume19
Issue number10
StatePublished - Oct 2007

Fingerprint

Tumor Biomarkers
Early Detection of Cancer
Urinary Bladder Neoplasms
Urine
Hematuria
Cost-Benefit Analysis
Cell Biology
Survival
Research
Neoplasms

ASJC Scopus subject areas

  • Medical–Surgical
  • Urology
  • Advanced and Specialized Nursing

Cite this

Bladder cancer screening : An update on urine-based tumor markers. / Svatek, Robert S.; Lotan, Yair.

In: Contemporary Urology, Vol. 19, No. 10, 10.2007, p. 12-19.

Research output: Contribution to journalArticle

@article{2b461f6840b747fbb2a065348392d38f,
title = "Bladder cancer screening: An update on urine-based tumor markers",
abstract = "Bladder cancer screening has the potential to improve survival in high-risk patients by detecting tumors early, resulting in better outcomes. While some urine-based bladder tumor markers have demonstrated an improvement in bladder cancer detection over cytology or hematuria testing, they need to be evaluated in the setting of screening. More research is required to assess the feasibility and cost-effectiveness of screening prior to widespread use.",
author = "Svatek, {Robert S.} and Yair Lotan",
year = "2007",
month = "10",
language = "English (US)",
volume = "19",
pages = "12--19",
journal = "Contemporary Urology",
issn = "1042-2250",
publisher = "Advanstar Communications",
number = "10",

}

TY - JOUR

T1 - Bladder cancer screening

T2 - An update on urine-based tumor markers

AU - Svatek, Robert S.

AU - Lotan, Yair

PY - 2007/10

Y1 - 2007/10

N2 - Bladder cancer screening has the potential to improve survival in high-risk patients by detecting tumors early, resulting in better outcomes. While some urine-based bladder tumor markers have demonstrated an improvement in bladder cancer detection over cytology or hematuria testing, they need to be evaluated in the setting of screening. More research is required to assess the feasibility and cost-effectiveness of screening prior to widespread use.

AB - Bladder cancer screening has the potential to improve survival in high-risk patients by detecting tumors early, resulting in better outcomes. While some urine-based bladder tumor markers have demonstrated an improvement in bladder cancer detection over cytology or hematuria testing, they need to be evaluated in the setting of screening. More research is required to assess the feasibility and cost-effectiveness of screening prior to widespread use.

UR - http://www.scopus.com/inward/record.url?scp=35348974066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348974066&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:35348974066

VL - 19

SP - 12

EP - 19

JO - Contemporary Urology

JF - Contemporary Urology

SN - 1042-2250

IS - 10

ER -